Key result
Non-alcoholic fatty liver disease in type 2 diabetic patients was associated with a lower prevalence of diabetic retinopathy compared to those without NAFLD (37.2% vs 46.6%, P=0.065).
Why the study?
Is the presence of non-alcoholic fatty liver disease (NAFLD) associated with the presence of diabetic retinopathy (DR) in patients with type 2 diabetes mellitus?
Cross-Sectional (n=411)
Is the presence of non-alcoholic fatty liver disease (NAFLD) associated with the presence of diabetic retinopathy (DR) in patients with type 2 diabetes mellitus?
Answers are grounded in this paper and cite their sources.
In patients with type 2 diabetes, the presence of NAFLD is associated with a lower prevalence of diabetic retinopathy, which appears to be mainly due to a shorter duration of diabetes.
To analyze the association between non-alcoholic fatty liver disease (NAFLD) and the presence of diabetic retinopathy (DR) in patients with type 2 diabetes mellitus (T2DM).Total 411 T2DM patients were divided into NAFLD and control groups. NAFLD was diagnosed by ultrasound. Retinopathy was diagnosed by fundus photography. All patients were screened based on medical history, physical examinations, and laboratory measurements.The prevalence of NAFLD and DR in T2DM patients was 60.8% and 40.9%, respectively. The presence of DR was associated with diabetes duration, systolic blood pressure (SBP), glycated hemoglobin (HbA1c), and proteinuria (all P < .001) using univariate and multivariate regression analyses. The prevalence of DR was lower in patients with NAFLD than those without NAFLD (37.2% vs 46.6%, P = .065), and significantly lower in patients with moderate and severe NAFLD (30.2% vs 46.6%, P = .012; 14.3% vs 46.6%, P = .024). The presence of DR in NAFLD patients was associated with diabetes duration (P = .032) in Chi-squared analysis.NAFLD and DR were highly prevalent in T2DM patients. Diabetes duration, SBP, HbA1c, and proteinuria were risk factors for DR in T2DM patients. The presence of DR was lower in T2DM patients with NAFLD, which was mainly due to their shorter diabetes duration.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2019) conducted a cross-sectional in Type 2 diabetes mellitus (n=411). Non-alcoholic fatty liver disease (NAFLD) vs. Without NAFLD was evaluated on Presence of diabetic retinopathy (p=0.065). Non-alcoholic fatty liver disease in type 2 diabetic patients was associated with a lower prevalence of diabetic retinopathy compared to those without NAFLD (37.2% vs 46.6%, P=0.065).
Synapse has enriched 10 related papers. Consider them for comparative context: